Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. has scheduled a board meeting on October 30, 2024, to review and approve its third-quarter financial results for the period ending September 30, 2024. The outcome of this meeting could provide valuable insights into the company’s performance for interested investors.
For further insights into HK:9989 stock, check out TipRanks’ Stock Analysis page.